newsfilter
← Latest News
GlobeNewswire·

Ambrx Biopharma to Host Corporate Update Conference Call

SAN DIEGO, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx, (NYSE:AMAM), a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision